1. Home
  2. TMDX vs PAR Comparison

TMDX vs PAR Comparison

Compare TMDX & PAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TMDX
  • PAR
  • Stock Information
  • Founded
  • TMDX 1998
  • PAR 1968
  • Country
  • TMDX United States
  • PAR United States
  • Employees
  • TMDX N/A
  • PAR N/A
  • Industry
  • TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • PAR Office Equipment/Supplies/Services
  • Sector
  • TMDX Health Care
  • PAR Miscellaneous
  • Exchange
  • TMDX Nasdaq
  • PAR Nasdaq
  • Market Cap
  • TMDX 4.8B
  • PAR 2.7B
  • IPO Year
  • TMDX 2019
  • PAR N/A
  • Fundamental
  • Price
  • TMDX $113.93
  • PAR $69.06
  • Analyst Decision
  • TMDX Buy
  • PAR Strong Buy
  • Analyst Count
  • TMDX 10
  • PAR 7
  • Target Price
  • TMDX $127.33
  • PAR $79.86
  • AVG Volume (30 Days)
  • TMDX 866.2K
  • PAR 436.2K
  • Earning Date
  • TMDX 07-30-2025
  • PAR 08-07-2025
  • Dividend Yield
  • TMDX N/A
  • PAR N/A
  • EPS Growth
  • TMDX N/A
  • PAR N/A
  • EPS
  • TMDX 1.41
  • PAR N/A
  • Revenue
  • TMDX $488,227,000.00
  • PAR $383,768,000.00
  • Revenue This Year
  • TMDX $34.07
  • PAR $30.06
  • Revenue Next Year
  • TMDX $20.76
  • PAR $16.97
  • P/E Ratio
  • TMDX $79.83
  • PAR N/A
  • Revenue Growth
  • TMDX 64.43
  • PAR 37.95
  • 52 Week Low
  • TMDX $55.00
  • PAR $43.50
  • 52 Week High
  • TMDX $177.37
  • PAR $82.24
  • Technical
  • Relative Strength Index (RSI)
  • TMDX 34.85
  • PAR 58.95
  • Support Level
  • TMDX $122.48
  • PAR $65.57
  • Resistance Level
  • TMDX $127.97
  • PAR $70.89
  • Average True Range (ATR)
  • TMDX 5.69
  • PAR 1.98
  • MACD
  • TMDX -2.22
  • PAR 0.23
  • Stochastic Oscillator
  • TMDX 17.42
  • PAR 79.49

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

About PAR PAR Technology Corporation

PAR Technology Corp is a foodservice technology company providing omnichannel cloud-based software and hardware solutions to the restaurant industry in three restaurant categories - quick service, fast casual, and table service - and the retail industry, including convenience and fuel retailers (C-Stores). The company's product and service offerings include point-of-sale, customer engagement and loyalty, digital ordering and delivery, operational intelligence, payment processing, hardware, and related technologies, solutions, and services. The company generates revenue from subscription service, Sale of Hardware products, and Professional Service.

Share on Social Networks: